FDG-PET evaluation of indeterminate pancreatic masses

Journal of Computer Assisted Tomography

Volumn 20, Issue 3, 1996, Pages 363-369

  Ho, Chi Lai ^a   Dehdashti, Farrokh ^a   Griffeth, Landis K ^a   Buse, Paul E ^b   Balfe, Dennis M ^a   Siegel, Barry A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Emission computed tomography; Fluorodeoxyglucose (FDG); Pancreas, neoplasms; Pancreatitis

Indexed keywords

COMPUTERIZED TOMOGRAPHY; GLUCOSE;

BENIGN LESION; EMISSION COMPUTED TOMOGRAPHY; FLUORO 2 DEOXY D GLUCOSE; FLUORODEOXYGLUCOSE; INDETERMINATE MASS; PANCREAS NEOPLASM; PANCREATIC CARCINOMA; PANCREATITIS; STANDARDIZED UPTAKE VALUES;

DIAGNOSIS;

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; FEMALE; HUMAN; MALE; PANCREAS ADENOCARCINOMA; PANCREAS CARCINOMA; PANCREAS SCINTISCANNING; PANCREATITIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOISOTOPE DISTRIBUTION;

EID: 0029972790     PISSN: 03638715     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004728-199605000-00006     Document Type: Article

References (36)

1. Parker SL, Tong T, Belden S, Wingo PA. Cancer statistics, 1996. CA Cancer J Clin 1996;46:5-27.
2. Brennan MF, Kinsella TJ, Casper ES. Cancer of the pancreas. In: Devita VT Jr, Hellman S, Rosenberg SA, eds. Cancer: principles and practice of oncology, vol 1. 4th ed. Philadelphia: Lippincott, 1993:849-82.
3. Gudjonsson B, Livestone EM, Spiro HM. Cancer of the pancreas. Diagnostic accuracy and survival statistics. Cancer 1978;42:2494-506.
4. Freeny PC. Radiologie diagnosis and staging of pancreatic ductal adenocarcinoma. Radiol Clin North Am 1989;27: 121-8.
5. Freeny PC. Radiology of pancreas: two decades of progress in imaging and intervention. AJR 1988;150:975-81.
6. Steiner E, Stark DD, Hahn PF, et al. Imaging of pancreatic neoplasms: comparison of MR and CT. AJR 1989;152:487-91.
7. Warshaw AL, Swanson RS. Pancreatic cancer in 1988. Possibilities and probabilities. Ann Surg 1988;208:541-53.
8. Glaspy JA, Hawkins R, Hoh CK, Phelps ME. Use of positron emission tomography in oncology. Oncology 1993;7:41-50.
9. Patz EF, Lowe VJ, Huffman JM, et al. Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning. Radiology 1993;188:487-90.
10. Adler LP, Crowe JP, Al-Kaisi NK, Sunshine JL. Evaluation of breast masses and axillary lymph nodes with [F-18] 2-deoxy-2-fluoro-D-glucose PET. Radiology 1993;187:743-50.
11. Griffeth LK, Dehdashti F, McGuire AH, et al. PET evaluation of soft-tissue masses with fluorine-18 fluoro-2-deoxy-D-glucosc. Radiology 1992;182:185-94.
12. Stollfuss JC, Glatting G, Friess H, Kocher F, Beger HG, Reske SN. 2-(Fluorine-18)-fluoro-2-deoxy-D-glucose PET in detection of pancreatic cancer: value of quantitative image interpretation. Radiology 1995;195:339-44.
13. Bares R, Klever P, Hauptmann S, et al. F-18 fluorodeoxy glucose PET in vivo evaluation of pancreatic glucose metabolism for detection of pancreatic cancer. Radiology 1994; 192:79-86.
14. Inokuma T, Tamaki N, Torizuka T, et al. Evaluation of pancreatic tumors with positron emission tomography and F-18 fluorodeoxyglucose: comparison with CT and US. Radiology 1995;195:345-52.
15. Kato T, Fukatsu H, Ito K, et al. Fluorodeoxyglucose positron emission tomography in pancreatic cancer: an unsolved problem. Eur J Nucl Med 1995;22:32-9.
16. Kubota K, Matsuzawa T, Ito M, et al. Lung tumor imaging by positron emission tomography using C-11 L-methionine. J Nucl Med 1985;26:37-42.
17. Langen KJ, Braun U, Rota Kops E, et al. The influence of plasma glucose levels on fluorine-18-fluorodeoxyglucose uptake in bronchial carcinomas. J Nucl Med 1993;34:355-9.
18. Ward EM, Stephens DH, Sheedy PF II. Computed tomography characteristics of pancreatic carcinoma: an analysis of 100 cases. Radiographics 1983;3:547-64.
19. Lammer J, Herlinger H, Zalaudek G, Hofler H. Pseudotumorous pancreatitis. Gastrointest Radiol 1985;10:59-67.
20. Neff CC, Simeone JF, Wittenberg J, Mueller PR, Ferrucci JT Jr. Inflammatory pancreatic masses: problems in differentiating focal pancreatitis from carcinoma. Radiology 1984; 150:35-8.
21. Schulte SJ, Baron RL, Freeny PC, Patten RM, Gorell HA, Maclin ML. Root of the superior mesenteric artery in pancreatitis and pancreatic carcinoma: evaluation with CT. Radiology 1991;180:659-62.
22. Syrota A, Duquesnoy N, Paraf A, Kellershohn C. The role of positron emission tomography in the detection of pancreatic disease. Radiology 1982;143:249-53.
23. 11C]methionine for measuring in vivo protein synthesis rates with PET. J Nucl Med 1988;29:1419-27.
24. Warburg O. The metabolism of tumors. New York: Richard B. Smith, 1931:129-169.
25. Hawkins RA, Choi Y, Huang S-C, Messa C, Hoh CK, Phelps ME. Quantitating tumor glucose metabolism with FDG and PET. J Nucl Med 1992;33:339-44.
26. Wahl RL, Quint LE, Greenough RL, Meyer CR, White RI, Orringer MB. Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation. Radiology 1994;191:371-7.
27. Inoue T, Kim EE, Komaki R, et al. Detecting recurrent or residual lung cancer with FDG-PET. J Nucl Med 1995;36: 788-93.
28. Patz EF Jr, Lowe VJ, Hoffman JM, Paine SS, Harris LK, Goodman PC. Persistent or recurrent bronchogenic carcinoma: detection with PET and 2-[F-18]-2-deoxy-D-glucose. Radiology 1994;191:379-82.
29. Ito K, Kato T, Tadokoro M, et al. Recurrent rectal cancer and scar: differentiation with PET and MR imaging. Radiology 1992;182:549-52.
30. Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T. Intratumoral distribution of fluorine-18-fluorodeoxy-glucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 1992;33:1972-80.
31. Wahl RL, Henry CA, Ethier SP. Serum glucose: effects on tumor and normal tissue accumulation of 2-[F-18]-fluoro-2-deoxy-D-glucose in rodents with mammary carcinoma. Radiology 1992;183:643-7.
32. Lindholm P, Minn H, Leskinen-Kallio S, Bergman J, Ruot- salainen U, Joensuu H. Influence of the blood glucose concentration on FDG uptake in cancer - a PET study. J Nucl Med 1993;34:1-6.
33. Bares R, Klever P, Hellwig D. Pancreatic cancer detected by positron emission tomography with F-18 labelled deoxyglucose: method and first results. Nucl Med Commun 1993;14: 596-601.
34. Langhans J, Fries H, Kornrumpf D, et al. Diagnosis of pancreas cancer with positron-emission-tomography (PET) and fluorine-18 2-deoxyglucose (FDG): differentiation from chronic pancreatitis [Abstract]. J Nucl Med 1993;34:225P.
35. Steinberg WM, Gelfand R, Anderson KK, et al. Comparison of the sensitivity and specificity of CA 19-9 and carcinoembryonic antigen assays in detecting cancer of the pancreas. Gastroenterology 1986;90:343-9.
36. Pasquali C, Sperti C, D'Andrea AA, et al. Evaluation of carbohydrate antigens 19-9 and 12-5 in patients with pancreatic cancer. Pancreas 1987;2:34-7.